These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32533869)

  • 21. Clinical and Molecular Characterization of Hyperinsulinism in Kabuki Syndrome.
    Rosenfeld E; Mitteer LM; Boodhansingh K; Sanders VR; McKnight H; De Leon DD
    J Endocr Soc; 2024 May; 8(7):bvae101. PubMed ID: 38859884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.
    Wang Y; Li N; Su Z; Xu Y; Liu S; Chen Y; Li X; Shen Y; Hung C; Wang J; Wang X; Bodamer O
    Am J Med Genet A; 2020 Apr; 182(4):640-651. PubMed ID: 31883305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel KMT2D mutations in two Chinese children with Kabuki syndrome: a case report and systematic literature review.
    Xin C; Wang C; Wang Y; Zhao J; Wang L; Li R; Liu J
    BMC Med Genet; 2018 Feb; 19(1):31. PubMed ID: 29482518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A narrative review on pathogenetic mechanisms of hyperinsulinemic hypoglycemia in Kabuki syndrome.
    Maines E; Maiorana A; Leonardi L; Piccoli G; Soffiati M; Franceschi R
    Endocr Regul; 2023 Jan; 57(1):128-137. PubMed ID: 37285460
    [No Abstract]   [Full Text] [Related]  

  • 25. Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.
    Wang YR; Xu NX; Wang J; Wang XM
    World J Pediatr; 2019 Dec; 15(6):528-535. PubMed ID: 31587141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2).
    Banka S; Lederer D; Benoit V; Jenkins E; Howard E; Bunstone S; Kerr B; McKee S; Lloyd IC; Shears D; Stewart H; White SM; Savarirayan R; Mancini GM; Beysen D; Cohn RD; Grisart B; Maystadt I; Donnai D
    Clin Genet; 2015 Mar; 87(3):252-8. PubMed ID: 24527667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.
    Faundes V; Malone G; Newman WG; Banka S
    J Hum Genet; 2019 Feb; 64(2):161-170. PubMed ID: 30459467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kabuki syndrome: clinical and molecular diagnosis in the first year of life.
    Dentici ML; Di Pede A; Lepri FR; Gnazzo M; Lombardi MH; Auriti C; Petrocchi S; Pisaneschi E; Bellacchio E; Capolino R; Braguglia A; Angioni A; Dotta A; Digilio MC; Dallapiccola B
    Arch Dis Child; 2015 Feb; 100(2):158-64. PubMed ID: 25281733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis.
    Kawai T; Iwasaki Y; Ogata-Kawata H; Kamura H; Nakamura K; Hata K; Takano T; Nakabayashi K
    Eur J Med Genet; 2023 Aug; 66(8):104806. PubMed ID: 37379880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kabuki Syndrome-Clinical Review with Molecular Aspects.
    Boniel S; Szymańska K; Śmigiel R; Szczałuba K
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
    Yoon JH; Hwang S; Bae H; Kim D; Seo GH; Koh JY; Ju YS; Do HS; Kim S; Kim GH; Kim JH; Choi JH; Lee BH
    J Hum Genet; 2024 Sep; 69(9):417-423. PubMed ID: 38824232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Congenital hyperinsulinism as a part of Kabuki syndrome].
    Benina AR; Melikyan MA
    Probl Endokrinol (Mosk); 2022 Jul; 68(5):91-96. PubMed ID: 36337023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kabuki syndrome as a cause of non-immune fetal hydrops/ascites.
    Long A; Sinkovskaya ES; Edmondson AC; Zackai E; Schrier Vergano SA
    Am J Med Genet A; 2016 Dec; 170(12):3333-3337. PubMed ID: 27568880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndromic Forms of Hyperinsulinaemic Hypoglycaemia-A 15-year follow-up Study.
    Kostopoulou E; Dastamani A; Güemes M; Clement E; Caiulo S; Shanmugananda P; Dattani M; Gilbert C; Hurst JA; Shah P
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):399-412. PubMed ID: 33345357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting KMT2D missense mutations in Kabuki syndrome patients.
    Cocciadiferro D; Augello B; De Nittis P; Zhang J; Mandriani B; Malerba N; Squeo GM; Romano A; Piccinni B; Verri T; Micale L; Pasqualucci L; Merla G
    Hum Mol Genet; 2018 Nov; 27(21):3651-3668. PubMed ID: 30107592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal Kabuki syndrome caused by KMT2D mutation: A case report.
    Li Z; Ning Z
    Medicine (Baltimore); 2023 Dec; 102(50):e36681. PubMed ID: 38115267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemia and Dandy-Walker variant in a Kabuki syndrome patient: a case report.
    Guo W; Zhao Y; Li S; Wang J; Liu X
    BMC Med Genet; 2020 Oct; 21(1):193. PubMed ID: 33008324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel
    Salguero MV; Chan K; Greeley SAW; Dyamenahalli U; Waggoner D; Del Gaudio D; Rajiyah T; Lemelman M
    J Endocr Soc; 2022 Apr; 6(4):bvac015. PubMed ID: 35237736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation.
    de Billy E; Strocchio L; Cacchione A; Agolini E; Gnazzo M; Novelli A; De Vito R; Capolino R; Digilio MC; Caruso R; Mastronuzzi A; Locatelli F
    Am J Med Genet A; 2019 Jan; 179(1):113-117. PubMed ID: 30569626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.
    Schott DA; Stumpel CTRM; Klaassens M
    Am J Med Genet A; 2019 Feb; 179(2):219-223. PubMed ID: 30556359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.